OS Therapies Incorporated (OSTX)
NYSEAMERICAN: OSTX · Real-Time Price · USD
1.820
-0.040 (-2.15%)
At close: Sep 10, 2026, 4:00 PM EDT
1.800
-0.020 (-1.10%)
After-hours: Sep 10, 2026, 5:53 PM EDT
OS Therapies Earnings Call Transcripts
Fiscal Year 2025
-
A novel Listeria-based immunotherapy platform is advancing toward regulatory approval for pediatric osteosarcoma, with strong phase II-B results and alignment with US, UK, and EU agencies. The company anticipates significant value from a Priority Review Voucher and is expanding into animal health and additional cancer indications.